C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.
Summary
During the peak of the second COVID -19 wave, the hospitals were over-crowded. Many COVID -19 positive patients had to stay at home and reach out to their family physicians for guidance. Medical follow-up for these patients was a daunting challenge. As in - patient hospital facilities were not readily accessible due to over crowding, early objective tests to identify home quarantined patients prone to deterioration and timely medical intervention to avoid hospitalization were required. Based on early assessment of inflammatory markers like CRP and clinical signs like persistent high-grade fever, need-based early medical intervention was initiated in home quarantined COVID -19 patients prior to the onset of hypoxia, in order to avoid complications and hospitalization
Timeline
- Start
- 2021-04-15
- Primary completion
- 2021-05-09
- Completion
- 2021-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | — | Oral |
| Subject | Azithromycin | Small molecule | — | Oral |
| Subject | Ceftriaxone | Other / unclassified | — | Intravenous |
| Subject | Cetirizine | Other / unclassified | — | Oral |
| Subject | Dexamethasone | Small molecule | — | Intravenous |
| Subject | Methylprednisolone | Other / unclassified | — | Oral |
| Subject | Rivaroxaban | Other / unclassified | — | Oral |
| Subject | Vitamin C | Other / unclassified | — | Oral |
| Subject | Vitamin D | Other / unclassified | — | Oral |
| Subject | Zinc Sulfate | Unknown | — | Oral |